FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Egil Lien

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Procedures

Concepts & Ideas

Biological Markers

Co-author Network

Publications

TOP 3
Lars Heggelund; Trude H Flo; Kristin Berg; Egil Lien; Tom Eirik Mollnes; Thor Ueland; Pål Aukrust; Terje Espevik; Stig S Frøland
Soluble toll-like receptor 2 in HIV infection: association with disease progression.
Lars Heggelund; Jan Kristian Damås; Arne Yndestad; Are M Holm; F Mūller; Egil Lien; Terje Espevik; Pål Aukrust; Stig S Frøland
Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences.
Lars Heggelund; Fredrik Müller; Egil Lien; Arne Yndestad; Thor Ueland; Knut Ivan Kristiansen; Terje Espevik; Pål Aukrust; Stig S Frøland
Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Egil Lien (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Lars Heggelund; Trude H Flo; Kristin Berg; Egil Lien; Tom Eirik Mollnes; Thor Ueland; Pål Aukrust; Terje Espevik; Stig S Frøland
Soluble toll-like receptor 2 in HIV infection: association with disease progression.
AIDS (London, England) 2004;18(18):2437-9.
2004: Lars Heggelund; Jan Kristian Damås; Arne Yndestad; Are M Holm; F Mūller; Egil Lien; Terje Espevik; Pål Aukrust; Stig S Frøland
Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences.
Clinical and experimental immunology 2004;138(1):116-21.
2004: Lars Heggelund; Fredrik Müller; Egil Lien; Arne Yndestad; Thor Ueland; Knut Ivan Kristiansen; Terje Espevik; Pål Aukrust; Stig S Frøland
Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(2):264-9.
2003: I Nordøy; Halvor Rollag; Egil Lien; H Sindre; Miklos Degré; Pål Aukrust; Stig S Frøland; Fredrik Müller
Cytomegalovirus infection induces production of human interleukin-10 in macrophages.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2003;22(12):737-41.
2002: Cybele Kristo; Kristin Godang; Thor Ueland; Egil Lien; Pål Aukrust; Stig S Froland; Jens Bollerslev
Raised serum levels of interleukin-8 and interleukin-18 in relation to bone metabolism in endogenous Cushing's syndrome.
European journal of endocrinology / European Federation of Endocrine Societies 2002;146(3):389-95.
2001: Lars Gullestad; Halfdan Aass; Arne K Andreassen; Halfdan Ihlen; Svein Simonsen; John Kjekshus; L Wikeby; Sigurd Nitter-Hauge; Jan G Fjeld; Egil Lien; Thor Ueland; Stig S Frøland; Pål Aukrust
[Immunomodulating treatment in advanced heart failure--effect of intravenous immunoglobulin].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2001;121(16):1902-7.
2001: Lars Gullestad; Halfdan Aass; Jan G Fjeld; L Wikeby; Arne K Andreassen; Halfdan Ihlen; Svein Simonsen; John Kjekshus; Sigurd Nitter-Hauge; Thor Ueland; Egil Lien; Stig S Frøland; Pål Aukrust
Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure.
Circulation 2001;103(2):220-5.
2001: Nina Beate Liabakk; Anders Waage; Egil Lien; J Stenvik; Terje Espevik
Cytokine bioassays.
Methods in molecular medicine 2001;67():487-97.
2000: I Nordøy; Fredrik Müller; Knut P Nordal; Halvor Rollag; Egil Lien; Pål Aukrust; Stig S Froland
The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients.
The Journal of infectious diseases 2000;181(1):51-7.
1999: I Nordøy; Fredrik Müller; Knut P Nordal; Halvor Rollag; Egil Lien; Pål Aukrust; Stig S Frøland
Immunologic parameters as predictive factors of cytomegalovirus disease in renal allograft recipients.
The Journal of infectious diseases 1999;180(1):195-8.
1999: Pål Aukrust; Thor Ueland; Egil Lien; Klaus Bendtzen; Fredrik Müller; Arne K Andreassen; I Nordøy; Halfdan Aass; Terje Espevik; Svein Simonsen; Stig S Frøland; Lars Gullestad
Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
The American journal of cardiology 1999;83(3):376-82.
1999: Pål Aukrust; CJ Haug; Thor Ueland; Egil Lien; Fredrik Müller; Terje Espevik; J Bollerslev; Stig S Frøland
Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy.
The Journal of clinical endocrinology and metabolism 1999;84(1):145-50.
1999: Pål Aukrust; Fredrik Müller; Egil Lien; I Nordoy; Nina Beate Liabakk; D Kvale; Terje Espevik; Stig S Froland
Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure.
The Journal of infectious diseases 1999;179(1):74-82.
1998: Fredrik Müller; Pål Aukrust; Egil Lien; CJ Haug; Stig S Frøland
Enhanced interleukin-10 production in response to Mycobacterium avium products in mononuclear cells from patients with human immunodeficiency virus infection.
The Journal of infectious diseases 1998;177(3):586-94.
1997: Pål Aukrust; Kjetil Hestdal; Egil Lien; Vigdis Bjerkeli; I Nordøy; Terje Espevik; Fredrik Müller; Stig S Frøland
Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-alpha activity in human immunodeficiency virus type 1 infection.
The Journal of infectious diseases 1997;176(4):913-23.
1997: Kjetil Hestdal; Pål Aukrust; Fredrik Müller; Egil Lien; Vigdis Bjerkeli; Terje Espevik; Stig S Frøland
Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load.
Blood 1997;90(7):2670-9.